Search results
Ky. receives naloxone shipment from drug company accused of fueling the opioid crisis
Lexington Herald-Leader McClatchy via AOL· 6 days agoGrants allowed Kentucky to distribute more than 160,000 two-dose units of Naloxone last year, Jody...
Missouri Family Health Council distributes nearly 25,000 free emergency contraception kits
KRCG· 18 hours agoThis comes as the Senate voted on and blocked legislation that protects access to contraception...
Neoadjuvant immunotherapy for early stage melanoma shows positive results
Medical Xpress· 3 days agoThe NADINA study, led by researchers from the Netherlands Cancer Institute, was named one of the...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoThe pair unveiled promising results in patients who received a combination of the cancer vaccine and...
New Oral Weight Loss Drugs: Where Are We and What's Next?
Medscape· 2 days agoNow that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 11 hours agoAs of Mar 31, 2024, Apellis had cash, cash equivalents and marketable securities worth $325.9...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool via Yahoo Finance· 11 hours agoThis week's upbeat news comes from NTLA-2002, a potential single-dose treatment for hereditary...
Why iRobot Stock Was Up 12% Last Month
Motley Fool via Yahoo Finance· 2 days agoBut iRobot only had positive cash flow because it received $75 million from Amazon when its planned acquisition of the company fell through....
GLP-1 Coverage Often Denied for Teens With Obesity
Medscape· 5 days agoFor those whose GLP-1 prescriptions were covered, few patients had good adherence to their treatment plans, and many did not reach their prescribed dose. "This has significant ...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via Yahoo News· 5 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...
